---
search:
  boost: 2 
---

# Corticosteroids

This is a subcategory of Topical Agents.

## Formulary

### Preferred

| Preferred                               | Generic Name | Quantity | Time (Days) |
| :-------------------------------------- | :----------- | :------: | :---------: |
| Amcinonide                              |              |          |             |
| Betamethasone Dip / Calcipotriene Oint  |              |          |             |
| Betamethasone Valerate                  |              |          |             |
| Clobetasol Propionate                   |              |          |             |
| Derma-Smoothe/FS <sup>BvG</sup>         |              |          |             |
| Desonide Cream, Oint                    |              |          |             |
| Diflorasone Diacetate                   |              |          |             |
| Fluocinolone Acetonide 0.01% Cream, Sol |              |          |             |
| Fluocinonide Acetonide 0.05%            |              |          |             |
| Flurandrenolide                         |              |          |             |
| Fluticasone Propionate Cream, Oint      |              |          |             |
| Hydrocortisone                          |              |          |             |
| Mometasone Furoate                      |              |          |             |
| Prednicarbate                           |              |          |             |
| Triamcinolone                           |              |          |             |

### Non-Preferred

| Non-Preferred                                   | Generic Name | Quantity | Time (Days) |
| :---------------------------------------------- | :----------- | :------: | :---------: |
| Alclometasone                                   |              |          |             |
| Apexicon E                                      |              |          |             |
| Betamethasone Dipropionate                      |              |          |             |
| Betamethasone Dipropionate / Calcipotriene Susp |              |          |             |
| Betamethasone Valerate Aerosol Foam             |              |          |             |
| Bryhali                                         |              |          |             |
| Clocortolone Pivalate                           |              |          |             |
| Cordran Tape                                    |              |          |             |
| Desonate Gel                                    |              |          |             |
| Desonide Lotion                                 |              |          |             |
| Desoximetasone                                  |              |          |             |
| Fluocinolone Acetonide 0.025%                   |              |          |             |
| Fluocinonide Acetonide 0.1%                     |              |          |             |
| Fluticasone Propionate Lotion                   |              |          |             |
| Halcinonide Cream                               |              |          |             |
| Halobetasol Propionate                          |              |          |             |
| Hydrocortisone Butyrate                         |              |          |             |
| Hydrocortisone Valerate                         |              |          |             |
| Halog                                           |              |          |             |
| Impeklo                                         |              |          |             |
| Pandel                                          |              |          |             |

## Length of Authorizations

365 days for low and medium potency

90 days for high and very high potency

## All Authorizations

Must be prescribed in accordance with FDA approved labeling

## Non-Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response to at least **14 days** with at least **two preferred** drugs
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

## Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment and ongoing safety monitoring

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL%20_Criteria_APPROVED.pdf#page=102)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL_APPROVED_12.13.22.pdf#page=32)

[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf)
